Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
1,832,497
-
Share change
-
+245,804
-
Total reported value
-
$8,263,970
-
Price per share
-
$4.51
-
Number of holders
-
31
-
Value change
-
+$1,145,345
-
Number of buys
-
16
-
Number of sells
-
6
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q3 2025
As of 30 Sep 2025,
Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,832,497 shares.
The largest 10 holders included
HighTower Advisors, LLC, LEVIN CAPITAL STRATEGIES, L.P., Kovitz Investment Group Partners, LLC, Mariner, LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, SATOVSKY ASSET MANAGEMENT LLC, Summit Financial, LLC, MORGAN STANLEY, and Private Advisor Group, LLC.
This page lists
31
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.